13 completed. 13 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 13 | Completed 13 |
| Phase 2 | 3 | Completed 3 |
Follow Hypopigmentation: new trials by email Literature Review of Hypopigmentation trials Research Report on Hypopigmentation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparative Study Between Topical 5-fluorouracil and Latanoprost in Vitiligo. Latanoprost 0.005% Ophthalmic Solution, 5Fluorouracil - Vitiligo | Phase 2 / Phase 3 | Completed | South Valley University | 40 | 2022-03-15 | 2023-07-11 |
| Assess the Long Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo ruxolitinib, Vehicle - Vitiligo | Phase 3 | Completed | Incyte Corporation | 458 | 2020-09-24 | 2025-08-14 |
| Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2) Ruxolitinib cream, Vehicle - Non-segmental Vitiligo | Phase 3 | Completed | Incyte Corporation | 344 | 2019-10-03 | 2025-08-22 |
| Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1) Ruxolitinib cream, Vehicle - Non-segmental Vitiligo | Phase 3 | Completed | Incyte Corporation | 330 | 2019-09-20 | 2025-08-22 |
| Efficacy of Tacrolimus in Adults With Facial Non-segmental Vitiligo - VITAC tacrolimus, Placebo - Vitiligo | Phase 3 | Completed | University Hospital, Bordeaux | 42 | 2016-02-23 | 2021-04-19 |
| Evaluation of Non-cultured Epidermal Cellular Grafting vs Hyaluronic Acid for Repigmenting Vitiligo and Piebaldism VITICELL, PLACEBO - Vitiligo, Piebaldism | Phase 3 | Completed | Laboratoires Genévrier | 38 | 2014-04-29 | 2019-10-14 |
| Epidermal Cell Transplantation in Vitiligo Skin Grafting with epidermal cells, UVB treatment - VITILIGO | Phase 2 / Phase 3 | Completed | Centre Hospitalier Universitaire de Nice | 23 | 2011-05-01 | 2013-05-30 |
| Interest of the Dermabrasion by Laser Erbium in the Treatment of the Vitiligo Group Laser = Arm A, Bras B : The group control - Vitiligo | Phase 2 / Phase 3 | Completed | Centre Hospitalier Universitaire de Nice | 20 | 2010-03-01 | 2012-03-26 |
| Excimer Lamp Versus Excimer Laser in Vitiligo Treatment 308nm excimer lamp, 308nm excimer laser - Vitiligo | Phase 3 | Completed | Centre Hospitalier Universitaire de Nice | 2009-03-17 | 2026-06-16 | |
| Autologous Transplantation of Melanocytes for Treatment of Vitiligo Skin Melanocyte transplantation - Vitiligo | Phase 3 | Completed | Royan Institute | 300 | 2009-02-01 | 2016-07-20 |
| Vitiligo Skin Transplantation Melanocyte-keratinocyte transplantation procedure (MKTP) - Vitiligo | Phase 3 | Completed | Henry Ford Health System | 40 | 2009-01-01 | 2012-09-06 |
| Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis Masitinib, Placebo, Best Supportive Care - Indolent Systemic Mastocytosis | Phase 3 | Completed | AB Science | 135 | 2008-12-01 | 2019-12-03 |
| Vitiligo Treated With TL01 Combined With Tacrolimus Ointment Versus Placebo Tacrolimus ointment - Vitiligo | Phase 3 | Completed | Oslo University Hospital | 2005-11-01 | 2008-12-12 |
Vitiligo (12) · Piebaldism (2) · Blushing (1) · Facies (1) · Mastocytosis (1) · Mastocytosis, Systemic (1) · Pruritus (1)
Pigmentation Disorders (13) · Skin Diseases (13) · Skin and Connective Tissue Diseases (13) · Albinism (2) · Amino Acid Metabolism, Inborn Errors (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Eye Diseases, Hereditary (2) · Genetic Diseases, Inborn (2) · Metabolic Diseases (2) · Metabolism, Inborn Errors (2) · Nutritional and Metabolic Diseases (2) · Pathological Conditions, Signs and Symptoms (2) · Skin Diseases, Genetic (2) · Behavior (1)
Cell Transplantation (1) · Cell- and Tissue-Based Therapy (1) · Fluorouracil (1) · Lasers, Excimer (1) · Latanoprost (1) · Ophthalmic Solutions (1) · Tacrolimus (1) · Transplantation (1) · masitinib (1) · ruxolitinib (1)
Centre Hospitalier Universitaire de Nice (3) · Incyte Corporation (3) · AB Science (1) · Henry Ford Health System (1) · Laboratoires Genévrier (1) · Oslo University Hospital (1) · Royan Institute (1) · South Valley University (1) · University Hospital, Bordeaux (1)
France (9) · United States (5) · Bulgaria (3) · Canada (3) · Germany (3) · Italy (3) · Poland (3) · Spain (3) · Netherlands (2) · Belgium (1) · Egypt (1) · Iran (1)
Kathleen Butler, MD (3) · Eli Johanne Nordal, MD (1) · Hassan M Ibrahim, professor (1) · Hossein Baharvand, PhD (1) · Iltefat H Hamzavi, MD (1) · Nanja Van Geel, Pr (1) · Nasser Aghdami, MD., PhD (1) · Olivier Lortholary, MD, PhD (1) · Saeeid Shafieian, MD (1)
PMID 41125994, PMID 36260792, PMID 40156697, PMID 20364383, PMID 28069279, PMID 33549606, PMID 39078582
2019 (2)